- Home
- PAVM vs FLGC Comparison
PAVM vs FLGC Comparison
Compare PAVM & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAVM | FLGC |
|---|---|---|
| Founded | 2014 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 7.6M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PAVM | FLGC |
|---|---|---|
| Price | $0.32 | $8.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 423.0K | 33.2K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $29,000.00 | ★ $57,609,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $450.56 | $0.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 24.71 |
| 52 Week Low | $0.30 | $6.80 |
| 52 Week High | $0.90 | $81.90 |
Technical Indicators
Market Signals| Indicator | PAVM | FLGC |
|---|---|---|
| Relative Strength Index (RSI) | 40.95 | 42.08 |
| Support Level | $0.32 | $9.28 |
| Resistance Level | $0.37 | $11.17 |
| Average True Range (ATR) | 0.03 | 1.38 |
| MACD | 0.00 | 0.32 |
| Stochastic Oscillator | 6.23 | 17.64 |
Price Performance
Historical ComparisonAbout PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.